Iron chelators as therapeutic agents for the treatment of cancer. (Q34671614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Iron chelators as therapeutic agents for the treatment of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Richardson DR

series ordinal

1

1 reference

3 August 2017

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

267-281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Demonstration of nitrogen coordination in metal-bleomycin complexes by electron spin-echo envelope spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Reduction of Ribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Enzymology of cancer cells (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Role of ribonucleotide reductase in expression in the neoplastic program.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Regulation of ribonucleotide reductase activity and its possible exploitation in chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Pharmacokinetics and pharmacodynamics of hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Binding of apotransferrin to K562 cells: explanation of the transferrin cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Modulation of cell surface iron transferrin receptors by cellular density and state of activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

The uptake of iron and transferrin by the human malignant melanoma cell

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Iron withholding: a defense against infection and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

The mechanisms of iron uptake by fetal rat hepatocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Cloning and characterization of a mammalian proton-coupled metal-ion transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

1 reference

7 January 2021

Transferrin and iron distribution in subcellular fractions of K562 cells in the early stages of transferrin endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Copper chaperones: function, structure and copper-binding properties.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

The ferritins: molecular properties, iron storage function and cellular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Control of cell proliferation by Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Iron Regulates the Intracellular Degradation of Iron Regulatory Protein 2 by the Proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Sequential expression of genes involved in human T lymphocyte growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Resistance to the antitumor agent gallium nitrate in human leukemic cells is associated with decreased gallium/iron uptake, increased activity of iron regulatory protein-1, and decreased ferritin production

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Identification of a hypoxia response element in the transferrin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Role of deferoxamine in tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Neuroblastomas contain iron-rich ferritin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Mechanism of inhibition of ribonucleoside diphosphate reductase by a-(N)-heterocyclic aldehyde thiosemicarbazones

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Synergistic Interaction of Kethoxal bis(Thiosemicarbazone) and Cupric Ions in Sarcoma 180

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Metabolic effects of zinc in intact cells—Comparative studies of zinc chloride and the zinc chelate of kethoxal bis(thiosemicarbazone)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Effect of iron-chelating agents on inhibitors of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Effective Iron Chelation following Oral Administration of an Isoniazid-Pyridoxal Hydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Cytotoxic chelators and chelates 1. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper(II) complex of salicylaldehyde benzoyl hydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Inhibition of the growth of cultured cells and an implanted fibrosarcoma by aroylhydrazone analogs of the Gly-His-Lys-Cu(II) complex

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Crystal and molecular structure of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: an iron chelator with anti-tumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Structure, function and regulation of p63 and p73.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Regulation and function of the p53-related proteins: same family, different rules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Promoter specificity and stability control of the p53-related protein p73

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Effect of iron chelators with potent anti-proliferative activity on the expression of molecules involved in cell cycle progression and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900218-9

7 January 2021

10.1016/S1040-8428(01)00218-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12050019%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference